BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33445954)

  • 1. Pharmacogenomics and prescription opioid use.
    Benjeddou M; Peiró AM
    Pharmacogenomics; 2021 Mar; 22(4):235-245. PubMed ID: 33445954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fundamental Considerations for Genetically-Guided Pain Management with Opioids Based on CYP2D6 and OPRM1 Polymorphisms.
    Ruano G; Kost JA
    Pain Physician; 2018 Nov; 21(6):E611-E621. PubMed ID: 30508992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of Opioid Pharmacogenetics and Considerations for Pain Management.
    Owusu Obeng A; Hamadeh I; Smith M
    Pharmacotherapy; 2017 Sep; 37(9):1105-1121. PubMed ID: 28699646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacogenetics of opioid treatment for pain management.
    Singh A; Zai C; Mohiuddin AG; Kennedy JL
    J Psychopharmacol; 2020 Nov; 34(11):1200-1209. PubMed ID: 32715846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case for genotype-guided pain management.
    Cavallari LH; Johnson JA
    Pharmacogenomics; 2019 Jul; 20(10):705-708. PubMed ID: 31368851
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacogenetics of opioids: a narrative review.
    Kumar S; Kundra P; Ramsamy K; Surendiran A
    Anaesthesia; 2019 Nov; 74(11):1456-1470. PubMed ID: 31454083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics of opioids and perioperative pain management.
    Sadhasivam S; Chidambaran V
    Pharmacogenomics; 2012 Nov; 13(15):1719-40. PubMed ID: 23171337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid genetics: the key to personalized pain control?
    Branford R; Droney J; Ross JR
    Clin Genet; 2012 Oct; 82(4):301-10. PubMed ID: 22780883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of CYP2D6 and OPRM1 pharmacogenetic testing for opioid therapy.
    Reynolds KK; Ramey-Hartung B; Jortani SA
    Clin Lab Med; 2008 Dec; 28(4):581-98. PubMed ID: 19059064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of pharmacogenomics and therapeutic drug monitoring for opioid pain management.
    Jannetto PJ; Bratanow NC
    Pharmacogenomics; 2009 Jul; 10(7):1157-67. PubMed ID: 19604091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pharmacogenetics approach to pain management.
    Yoshida K; Nishizawa D; Ide S; Ichinohe T; Fukuda KI; Ikeda K
    Neuropsychopharmacol Rep; 2018 Mar; 38(1):2-8. PubMed ID: 30106264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of perioperative pain management.
    Packiasabapathy S; Horn N; Sadhasivam S
    Curr Opin Anaesthesiol; 2018 Dec; 31(6):749-755. PubMed ID: 30239351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Implications of Opioid Pharmacogenomics in Patients With Cancer.
    Bell GC; Donovan KA; McLeod HL
    Cancer Control; 2015 Oct; 22(4):426-32. PubMed ID: 26678969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP2D6 phenotypes and opioid metabolism: the path to personalized analgesia.
    Ballester P; Muriel J; Peiró AM
    Expert Opin Drug Metab Toxicol; 2022 Apr; 18(4):261-275. PubMed ID: 35649041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Human Pain-Related Genotypes and Variability in Opioid Analgesia: An Updated Review.
    Nielsen LM; Olesen AE; Branford R; Christrup LL; Sato H; Drewes AM
    Pain Pract; 2015 Jul; 15(6):580-94. PubMed ID: 25201705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial.
    Smith DM; Weitzel KW; Elsey AR; Langaee T; Gong Y; Wake DT; Duong BQ; Hagen M; Harle CA; Mercado E; Nagoshi Y; Newsom K; Wright A; Rosenberg EI; Starostik P; Clare-Salzler MJ; Schmidt SO; Fillingim RB; Johnson JA; Cavallari LH
    Genet Med; 2019 Aug; 21(8):1842-1850. PubMed ID: 30670877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reviewing pharmacogenetics to advance precision medicine for opioids.
    Magarbeh L; Gorbovskaya I; Le Foll B; Jhirad R; Müller DJ
    Biomed Pharmacother; 2021 Oct; 142():112060. PubMed ID: 34523422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interindividual variation of pharmacokinetic disposition of and clinical responses to opioid analgesics in cancer pain patients].
    Naito T; Kawakami J
    Yakugaku Zasshi; 2015; 135(5):709-15. PubMed ID: 25948306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of opioids.
    Somogyi AA; Barratt DT; Coller JK
    Clin Pharmacol Ther; 2007 Mar; 81(3):429-44. PubMed ID: 17339873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacogenetics of opioid therapy in the management of postpartum pain: a systematic review.
    Baber M; Bapat P; Nichol G; Koren G
    Pharmacogenomics; 2016; 17(1):75-93. PubMed ID: 26652709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.